Skip to main content

Table 3 Consequences of the results of direct-to-consumer genetic tests on patients’ health behaviors, according to disease (% of patients answering “yes” to the questions)

From: May direct-to-consumer genetic testing have an impact on general practitioners’ daily practice? a cross-sectional study of patients’ intentions towards this approach

 

N

Gender

Age

Area

Total

Female

Male

p

 < 50

50–64

 >  = 65

p

Rural

Urban

p

Based on the test’s results, do you think that you would change your lifestyle?

 Diabetes

901

77.3

84.2

**

85.3

82.8

75.5

**

77.8

82.5

ns

81.1

 Colorectal cancer

879

78.6

82.3

ns

81.3

81.5

79.5

ns

79.9

81.2

ns

80.7

 Alzheimer’s disease

876

60.4

69.0

**

63.1

66.9

65.8

ns

59.8

67.0

ns

65.2

 Systematically, whatever the disease

882

54.0

62.5

*

57.1

62.3

57.2

ns

54.4

60.2

ns

58.7

Based on the test’s results, do you think you would like your GP to change your health management?

 Diabetes

868

46.1

49.3

ns

44.6

48.1

51.9

ns

43.3

49.1

ns

47.8

 Colorectal cancer

851

59.4

59.2

ns

61.2

58.1

57.3

ns

62.4

58.6

ns

59.1

 Alzheimer’s disease

867

53.9

57.8

ns

49.7

59.4

59.6

*

51.2

57.2

ns

55.9

 Systematically, whatever the disease

860

35.2

36.4

ns

34.5

38

34.4

ns

29.1

38.2

*

35.8

Based on the test’s results, do you think that you would ask your GP to perform complementary examinations more frequently?

 Diabetes

896

67.4

68.4

ns

73.7

67.1

61.8

**

68.3

67.8

ns

67.4

 Colorectal cancer

892

75.5

78.9

ns

81.6

78.6

70.9

**

76.8

77.5

ns

77.1

 Alzheimer’s disease

874

60.7

66.0

ns

67.2

63.9

58.4

**

55.9

65.7

**

63.2

 Systematically, whatever the disease

878

49.1

51.3

ns

56.3

50.8

42.1

**

44.4

52.2

*

49.9

  1. * 5.10–2 ≤ p < 10–2; ** 10–2 ≤ p ≤ 10–3; *** p ≤ 10–3; ns: not significant